Endocrinol Metab.  2016 Mar;31(1):62-63. 10.3803/EnM.2016.31.1.62.

Differentiated Thyroid Cancer in Asians

• Kim BH

• KMID: 2169693
• DOI: http://doi.org/10.3803/EnM.2016.31.1.62

Abstract

No abstract available.

MeSH Terms

Asian Continental Ancestry Group*
Humans
Thyroid Gland*
Thyroid Neoplasms*

Reference

1. Ito Y, Nikiforov YE, Schlumberger M, Vigneri R. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013; 9:178–184.

2. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic": screening and overdiagnosis. N Engl J Med. 2014; 371:1765–1767.

3. Kim TY, Kim WG, Kim WB, Shong YK. Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul). 2014; 29:217–225.

4. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–141.

5. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115:3801–3807.

6. Fernandes JK, Day TA, Richardson MS, Sharma AK. Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol. 2005; 6:47–57.

7. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007; 110:1451–1456.

8. Jin H, Pinheiro PS, Xu J, Amei A. Cancer incidence among Asian American populations in the United States, 2009-2011. Int J Cancer. 2016; 138:2136–2145.

9. Kolonel LN. Cancer incidence among Filipinos in Hawaii and the Philippines. Natl Cancer Inst Monogr. 1985; 69:93–98.

10. Goodman MT, Yoshizawa CN, Kolonel LN. Descriptive epidemiology of thyroid cancer in Hawaii. Cancer. 1988; 61:1272–1281.

11. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control. 2000; 11:163–170.

12. Kus LH, Shah M, Eski S, Walfish PG, Freeman JL. Thyroid cancer outcomes in Filipino patients. Arch Otolaryngol Head Neck Surg. 2010; 136:138–142.

13. Lo TE, Uy AT, Maningat PD. Well-differentiated thyroid cancer: the Philippine General Hospital experience. Endocrinol Metab (Seoul). 2016; 31:73–80.

14. Lo TE, Canto AU, Maningat PD. Risk factors for recurrence in Filipinos with well-differentiated thyroid cancer. Endocrinol Metab (Seoul). 2015; 30:543–550.

15. Verburg FA, Mader U, Tanase K, Thies ED, Diessl S, Buck AK, et al. Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013; 98:172–180.